111-120 of 553 results
Interlocutory injunction refused based on 'doubtful' patent term extension
In the fight against patent infringement, challenging the validity of patent term extensions (PTEs) is increasingly becoming the weapon of choice for generic pharmaceutical companies. Since around the mid-2000s, patentees in pharmaceutical patent cases have typically been successful in bids for interlocutory injunctions, aiming to prevent the launch of generic products in Australia. The recent Biogen decision by the Federal Court is the latest in a trend of refusing interlocutory injunctions, and a clear indication the tide is turning. ...
Antibody patent protection in Australia
Many of the top selling drugs in Australia are antibodies, all part of a global market estimated to reach US$140 billion this year. Recently, the US FDA (Food and Drug Administration) approved the ...
Nucleus – corporate law developments: virtual meetings and e-signing lead a raft of changes coming in 2022
After an extremely busy end to the year, we are pleased to present our snapshot of corporate law developments to the end of 2021. We wish you all the very best for the Christmas and New Year break, and look forward to bringing you further developments through Nucleus in 2022. ...
Lessons on product branding and trade mark use in the context of halal certification
In Halal Certification Authority v Flujo Sanguineo Holdings, the court dismissed Halal Certification Authority Pty Ltd's (HCA) claims of trade mark infringement, misleading or deceptive conduct and passing off against the Flujo Group of companies relating to the use of a halal-related trade mark, and ordered that its registration for that mark be cancelled. ...
Managing the risks of brand collaborations – a few top tips
Brand collaborations can create exciting commercial opportunities for businesses. However, they involve a number of risks. These include, for example, the possibility that a collaborator may suffer unexpected damage to their brand which makes the collaboration no longer commercially viable. Therefor ...
Overcoming roadblocks to blockchain inventions
In welcome news for technology innovators, a delegate of the Commissioner of Patents recently determined that certain blockchain inventions constituted patentable subject matter. ...
Expansion in scope of transactions subject to FIRB approval rules
In this Insight, we look at the changes and comment on what they mean for transactions. The changes to the SOCI Act also have operational implications for many businesses – which we will separately publish on. ...
Government sets out agenda for big changes to regulation of payments and digital assets
The Government's response paper — 'Transforming Australia's Payments System' — addresses the recent Review of the Australian Payments System, the report of the Senate Select Committee on Australia as a Technology and Financial Centre and the Parliamentary Joint Committee Corporations and Financial Services Report on Mobile Payment and Digital Wallet Financial Services. ...
In Touch: Highest total penalty amount ever imposed under ACL; and other developments
NAB acquisition of Citigroup Australia Pty Limited’s Aust consumer business; Turnitin LLC's acquisition of Ouriginal Group AB; Techtronic Industries Australia; JBS acquisition of Rivalea Holdings and Oxdale Dairy Enterprise; Compass Matin; Australian Institute of Professional Education Pty Ltd ...
In Touch: Meta cleared to acquire Kustomer; and other developments
Mereenie gas field joint marketing; Meta's acquisition of Kustomer; Alkaloids of Australia pleads guilty to criminal cartel charges; no appeal for Volkswagen; Please Hold agrees to amend contracts; Bare Cremation pays penalty for allegedly misleading consumers ...